Flash glucose monitoring in the diagnosis of insulinoma

• Leonid Yu. Morgunov
• Konstantin A. Pokrovskiy
• Otabek U. Kosimov

Abstract

Insulinoma is a rare pancreatic neuroendocrine tumor, manifested by hypersecretion of insulin. The frequency of occurrence does not exceed 1–3 cases per million per year. Many cases remain undiagnosed due to unexpressed clinical manifestations. In most patients, symptoms appear within 12–18 months after the appearance of the neoplasm, but can slowly progress for decades before a correct diagnosis is made. Basically, erroneous neurological or psychiatric diagnoses are initially established. Continuous flash glucose monitoring can significantly simplify this process and increase the accuracy of measurements, since continuous monitoring of glucose levels in interstitial fluid is carried out, allowing automatic measurement and real-time monitoring of its level. The relevance of flash glucose monitoring for the diagnosis and treatment of insulinoma is based on the need for constant and accurate monitoring of glycemic levels. With insulinoma, the patient has no sensitivity to the level of glycemia, and the autonomous secretion of insulin continues regardless of blood glucose levels. In such cases, continuous flash glucose monitoring helps to prevent hypoglycemic conditions in time and take appropriate measures. The paper presents a clinical case of a long-term course of insulinoma in the absence of timely diagnosis. In questionable situations, the use of flash glucose monitoring is recommended, which may be a priority method for detecting hypoglycemia in diseases associated with hyperinsulinism.

Keywords:insulinoma; flash glucose monitoring

References

1. Sakurai A., Yamazaki M., Suzuki S., Fukushima T., Imai T., Kikumori T., et al. Clinical features of insulinoma in patients with multiple endocrine neoplasia type 1: analysis of the database of the MEN Consortium of Japan. Endocr J. 2012; 59 (10): 859–66. DOI: https://doi.org/10.1507/endocrj. ej12-0173

2. de Herder W.W., Niederle B., Scoazec J.Y., Pauwels S., Kloppel G., Falconi M., et al.; Frascati Consensus Conference; European Neuroendocrine Tumor Society. Well-differentiated pancreatic tumor/carcinoma: insulinoma. Neuroendocrinology. 2006; 84 (3): 183–8. DOI: https://doi.org/10.1159/000098010

3. Giannis D., Moris D., Karachaliou G.S., Tsilimigras D.I., Karaolanis G., Papalampros A., et al. Insulinomas: from diagnosis to treatment. A review of the literature. J BUON. 2020; 25 (3): 1302–14.

4. Vaidakis D., Karoubalis J., Pappa T., Piaditis G., Zografos G.N. Pancreatic insulinoma: current issues and trends. Hepatobiliary Pancreat Dis Int. 2010; 9 (3): 234–41. PMID: 20525548.

5. Manusharova R.A., Cherkezov D.I. Insulinoma (clinical picture, diagnosis, treatment). Meditsinskiy sovet [Medical Council]. 2011; (1–2): 59–63. URL: https://cyberleninka.ru/article/n/insulinoma-klinika-diagnostika-i-lechenie (in Russian)

6. Nikfarjam M., Warshaw A.L., Axelrod L., Deshpande V., Thayer S.P., Ferrone C.R., et al. Improved contemporary surgical management of insulinomas: a 25-year experience at the Massachusetts General Hospital. Ann Surg. 2008; 247 (1): 165–72. DOI: https://doi.org/10.1097/SLA.0b013e31815792ed

7. Service F.J., McMahon M.M., O’Brien P.C., Ballard D.J. Functioning insulinoma – incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc. 1991; 66 (7): 711–9. DOI: https://doi.org/10.1016/s0025-6196(12)62083-7

8. Service F.J., Dale A.J., Elveback L.R., Jiang N.S. Insulinoma: clinical and diagnostic features of 60 consecutive cases. Mayo Clin Proc. 1976; 51 (7): 417–29. PMID: 180358.

9. ASGE Standards of Practice Committee; Eloubeidi M.A., Decker G.A., Chandrasekhara V., Chathadi K.V., Early D.S., Evans J.A., et al. The role of endoscopy in the evaluation and management of patients with solid pancreatic neoplasia. Gastrointest Endosc. 2016; 83 (1): 17–28. DOI: https://doi.org/10.1016/j.gie.2015.09.009

10. Okabayashi T., Shima Y., Sumiyoshi T., Kozuki A., Ito S., Ogawa Y., et al. Diagnosis and management of insulinoma. World J Gastroenterol. 2013; 19 (6): 829–37. DOI: https://doi.org/10.3748/wjg. v19.i6.829

11. Su A.P., Ke N.W., Zhang Y., Liu X.B., Hu W.M., Tian B.L., et al. Is laparoscopic approach for pancreatic insulinomas safe? Results of a systematic review and meta-analysis. J Surg Res. 2014; 186 (1): 126–34. DOI: https://doi.org/10.1016/j.jss.2013.07.051

12. Murakami T., Yamashita T., Yabe D., Masui T., Teramoto Y., Minamiguchi S., et al. Insulinoma with a history of epilepsy: still a possible misleading factor in the early diagnosis of insulinoma. Intern Med. 2017; 56 (23): 3199–204. DOI: https://doi.org/10.2169/internalmedicine.8932-17

13. Hayashida R., Tsuchiya K., Sekine T., Momose T., Sato F., Sakurada M., et al. A clinical case of insulinoma presenting with postprandial hypoglycemia in a patient with a history of gastric bypass surgery. Intern Med. 2022; 61 (8): 1189–95. DOI: https://doi.org/10.2169/internalmedicine.7428-21

14. Nakajima R., Idesawa H., Sato D., Ito J., Ito K., Fujii M., et al. Continuous glucose monitoring in a patient with insulinoma presenting with unawareness of postprandial hypoglycemia. Endocrinol Diabetes Metab Case Rep. 2023; 2023 (3): 23-0056. DOI: https://doi.org/10.1530/EDM-23-0056

15. Suminaga K., Murakami T., Yabe D., Sone M., Sugawa T., Masui T., et al. Factory-calibrated continuous glucose monitoring and capillary blood glucose monitoring in a case with insulinoma: usefulness and possible pitfall under chronic hyperinsulinemic hypoglycemia. Endocr J. 2020; 67 (3): 361–6. DOI: https://doi.org/10.1507/endocrj. EJ19-0339

16. Sugawa T., Murakami T., Yabe D., Kashima R., Tatsumi M., Ooshima S., et al. Hypoglycemia unawareness in insulinoma revealed with flash glucose monitoring systems. Intern Med. 2018; 57 (23): 3407–12. DOI: https://doi.org/10.2169/internalmedicine.1173-18

17. Ma J., Huang X., Zhao J., Lu J., Lu W., Bao Y., et al. CGM for insulinoma screening: a prospective and observational case-control study. Endocr Relat Cancer. 2021; 28 (5): 291–300. DOI: https://doi.org/10.1530/ERC-20-0447

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)